Indications for cardiovascular magnetic resonance imaging;Indikationen für kardiovaskuläre magnetresonanztomographie

Medizinische Klinik

Volumn 100, Issue 4, 2005, Pages 219-225

  Nagel, Eike ^b   Kelle, Sebastian ^a   Fleck, Eckart ^a  

^a Deutsche Herzzentrum Berlin ^*

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Cardiovascular magnetic resonance; Indications; Non invasive diagnostics; Perfusion; Stress examination

Indexed keywords

ADENOSINE; DOBUTAMINE;

ABDOMEN; ACCURACY; CARDIOMYOPATHY; CARDIOVASCULAR SYSTEM; CONGENITAL HEART MALFORMATION; CORONARY ARTERY; EXERCISE TEST; GREAT BLOOD VESSEL; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; IMAGE ANALYSIS; ISCHEMIC HEART DISEASE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT; PERFUSION; PERICARDIUM; QUANTITATIVE ANALYSIS; REVIEW; STANDARD; STRESS ECHOCARDIOGRAPHY; THORAX; TUMOR;

CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIAGNOSIS, DIFFERENTIAL; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; HEART DEFECTS, CONGENITAL; HEART NEOPLASMS; HEART VALVE DISEASES; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION;

EID: 17744377479     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-005-1026-0     Document Type: Review

References (55)

1. The clinical role of magnetic resonance in cardiovascular disease. Task Force of the European Society of Cardiology, in collaboration with the Association of European Paediatric Cardiologists. Eur Heart J 1998;19:19-39.
2. Pennell D, Sechtem U, Higgins C, et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 2004;25:1940-65.
3. Hundley WG, Li HF, Lange RA, et al. Assessment of left-to-right intracardiac shunting by velocity-encoded, phase-difference magnetic resonance imaging. A comparison with oximetric and indicator dilution techniques. Circulation 1995;91:2955-60.
4. Hoppe UC, Dederichs B, Deutsch HJ, et al. Congenital heart disease in adults and adolescents: comparative value of transthoracic and transesophageal echocardiography and MR imaging. Radiology 1996;199:669-77.
5. Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002;90:29-34.
6. Bellenger NG, Burgess MI, Ray SG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? Eur Heart J 2000;21:1387-96.
7. Grothues F, Moon JC, Bellenger NG, et al. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 2004;147:218-23.
8. Lorenz CH, Walker ES, Morgan VL, et al. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999;1:7-21.
9. Tscholakoff D, Sechtem U, de Geer G, et al. Evaluation of pleural and pericardial effusions by magnetic resonance imaging. Eur J Radiol 1987;7:169-74.
10. Mogelvang J, Lindvig K, Sondergaard L, et al. Reproducibility of cardiac volume measurements including left ventricular mass determined by MRI. Clin Physiol 1993;13:587-97.
11. Kozerke S, Scheidegger MB, Pedersen EM, et al. Heart motion adapted cine phase-contrast flow measurements through the aortic valve. Magn Reson Med 1999;42:970-8.
12. Hundley WG, Li HF, Willard JE, et al. Magnetic resonance imaging assessment of the severity of mitral regurgitation. Comparison with invasive techniques. Circulation 1995;92:1151-8.
13. Sondergaard L, Lindvig K, Hildebrandt P, et al. Quantification of aortic regurgitation by magnetic resonance velocity mapping. Am Heart J 1993;125:1081-90.
14. Chatzimavroudis GP, Oshinski JN, Pettigrew RI, et al. Quantification of mitral regurgitation with MR phase-velocity mapping using a control volume method. J Magn Reson Imaging 1998;8:577-82.
15. Meaney JF, Prince MR, Nostrant TT, et al. Gadolinium-enhanced MR angiography of visceral arteries in patients with suspected chronic mesenteric ischemia. J Magn Reson Imaging 1997;7:171-6.
16. Nienaber CA, Kodolitsch Y von, Nicolas Y et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl J Med 1993;328:1-9.
17. Sommer T, Fehske W, Holzknecht N, et al. Aortic dissection: a comparative study of diagnosis with spiral CT, mutiplanar transesophageal echocardiography, and MR imaging. Radiology 1996;199:347-52.
18. Pereles FS, McCarthy RM, Baskaran V, et al. Thoracic aortic dissection and aneurysm: evaluation with nonenhanced true FISP MR angiography in less than 4 minutes. Radiology 2002;223:270-4.
19. Leung DA, Hagspiel KD, Angle JF, et al. MR angiography of the renal arteries. Radiol Clin North Am 2002;40:847-65.
20. Ruehm SG, Goyen M, Barkhausen J, et al. Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 2001;357:1086-91.
21. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999;99:763-70.
22. Wahl A, Paetsch I, Roethemeyer S, et al. High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest. Radiology 2004;233:210-6.
23. Wahl A, Paetsch I, Gollesch A, et al. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: experience in 1000 consecutive cases. Eur Heart J 2004;25:1230-6.
24. Nagel E, Lorenz C, Baer F, et al. Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson 2001;3:267-81.
25. Kuijpers D, Ho KY, van Dijkman PR, et al. Dobutamine cardiovascular magnetic resonance for the detection of myocardial ischemia with the use of myocardial tagging. Circulation 2003;107:1592-7.
26. Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 2004;109:2172-4.
27. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000;101:1379-83.
28. Nagel E, Klein C, Paetsch I, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003;108:432-7.
29. Al-Saadi N, Nagel E, Gross M. et al. Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging. J Am Coll Cardiol 2000;36:1557-64.
30. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-5.
31. Wolff SD, Schwitter J, Coulden R, et al. Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study Circulation 2004;110:732-7.
32. Giang TH, Nanz D, Coulden R, et al. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J 2004;25:1657-65.
33. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-53.
34. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92:1902-10.
35. Kim RJ, Wu E, Rafael A, et al.The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
36. Klein C, Nekolla SG, Beugel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-7.
37. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-9.
38. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-72.
39. Choi KM, Kim RJ, Gubernikoff G, et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-7.
40. Langerak SE, Vliegen HW, Jukema JW, et al. Value of magnetic resonance imaging for the noninvasive detection of stenosis in coronary artery bypass grafts and recipient coronary arteries. Circulation 2003;107:1502-8.
41. Greil GF, Stuber M, Botnar RM, et al. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation 2002;105:908-11.
42. Bunce NH, Lorenz CH, Keegan J, et al. Coronary artery anomalies: assessment with free-breathing three-dimensional coronary MR angiography. Radiology 2003;227:201-8.
43. McConnell MV Ganz P, Selwyn AP, et al. Identification of anomalous coronary arteries and their anatomic course by magnetic resonance coronary angiography. Circulation 1995;92:3158-62.
44. Post JC, van Rossum AQ, Bronzwaer JG, et al. Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course? Circulation 1995;92:3163-71.
45. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001;345:1863-9.
46. Jahnke C, Paetsch I, Schnackenburg B, et al. Coronary MR angiography with steady-state free precession: individually adapted breath-hold technique versus free-breathing technique. Radiology 2004;232:669-76.
47. Klein C, Schalla S, Schnackenburg B, et al. Improvement of image quality of non-invasive coronary artery imaging with magnetic resonance by the use of the intravascular contrast agent Clariscan trade mark (NC100150 injection) in patients with coronary artery disease. J Magn Reson Imaging 2003;176:656-62.
48. Huber M, Paetsch I, Schnackenburg B, et al. Performance of a new gadolinium-based intravascular contrast agent in fee-breathing inversion-recovery 3D coronary MRA. Magn Reson Med 2003;49:115-21.
49. Herborn C, Barkhausen J, Paetsch I, et al. Coronary arteries: contrast-enhanced MR imaging with SH L 643A - experience in 12 volunteers. Radiology 2003;229:217-23.
50. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9.
51. Moon JC, McKenna WJ, McCrohon JA, et al.Toward clinical risk assessment in hypertrophie cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-7.
52. Choudhury L, Mahrholdt H, Wagner A, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:2156-64.
53. Anderson LJ, Wonke B, Prescott E, et al. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet 2002;360:516-20.
54. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-9.
55. Klein C, Graf K, Fleck E, et al. Images in cardiovascular medicine. Acute fibrinous pericarditis assessed with magnetic resonance imaging. Circulation 2003;107:e82.